IP Library Granted Patent US 7,022,503
Granted Patent B2
US 7,022,503 · App. 10/238,308 · Granted Apr 4, 2006

Process for the stereoselective preparation of functionalized vicinal diols

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,022,503
App. No.
10/238,308
Granted
Apr 4, 2006
Kind
B2
Abstract

The present invention relates to a process for the kinetic resolution of racemic functionalized epoxides in the presence of microorganisms, crude or pure preparations thereof comprising a polypeptide having epoxide hydrolase activity. Preferred microorganisms are yeasts and bacteria which may also be recombinant.

Claims (44)

1. A process for the stereoselective preparation of an 2,3-dihydroxy carboxylic acid and a derivative thereof, comprising

hydrolyzing a 2,3-epoxycarboxylic acid or a derivative thereof in the in the presence of a polypeptide having epoxide hydrolase activity,

wherein the 2,3-epoxycarboxylic acid or derivative has a formula (I)

wherein independently of each other

R 1 represents a cyano substituent and

R 2 represents hydrogen, straight-chain or branched, cyclic or acyclic C 1 –C 12 -alkyl, unsubstituted or substituted aryl and

R 3 represents hydrogen, straight-chain C 1 –C 12 -alkyl, or

R 2 R 3 C represents a carbocycle or a heterocycle.

2. The process according to claim 1 , wherein the process further comprises converting the 2,3-epoxycarboxylic acid or the 2,3-epoxycarboxylic acid derivative

to vicinal diols of the general formula (II)

wherein independently of each other

R 1 represents a cyano substituent and

R 2 represents hydrogen, straight-chain or branched, cyclic or acyclic C 1 –C 12 -alkyl, unsubstituted or substituted aryl and

R 3 represents hydrogen, straight-chain C 1 –C 12 -alkyl, or R 2 R 3 C represents a carbocycle or a heterocycle

in the presence of a polypeptide having epoxide hydrolase activity and which is derived from a microorganism.

3. The process according to claim 2 wherein the conversion is stopped when epoxides of the general formula (I)

wherein independently of each other

R 1 represents a cyano substituent and

R 2 and R 3 are identical and represent hydrogen, straight-chain C 1 –C 12 -alkyl or

R 2 R 3 C as whole represents a carbocycle

are converted to the correspoding vicinal diols of formula (II) wherein R 1 , R 2 and R 3 have the same meaning as mentioned above to such an extent that said vicinal diols have an enantiomeric excess of at least 90%.

4. The process according to claim 2 wherein the conversion is stopped when epoxides of the general formula (I)

wherein independently of each other

R 1 represents a cyano substituent and

R 2 and R 3 are identical and represent hydrogen, straight-chain C 1 –C 12 -alkyl or

R 2 R 3 C as whole represents a carbocycle

are converted to the correspoding vicinal diols of formula (II) wherein R 1 , R 2 and R 3 have the same meaning as mentioned above to such an extent that said vicinal diols have an enantiomeric excess of at least 95%.

5. The process according to claim 1 wherein the polypeptide having epoxide hydrolase activity is derived from a microorganism belonging to the basidiomycetous yeast genera Rhodotorula, Rhodosporidium or Trichosporon.

6. The process according to claim 5 wherein the polypeptide having epoxide hydrolase activity is derived from a microorganism belonging to the basidiomycetous yeast genera Rhodotorula or Rhodosporidium.

7. The process according to claim 6 wherein the polypeptide having epoxide hydrolase activity is derived from Rhodotorula glutinis, Rhodosporidium toruloides or Rhodosporidium toruloides.

8. The process according to claim 7 wherein the polypeptide having epoxide hydrolase activity is derived from Rhodotorula glutinis strain CBS 8761, Rhodotorula glutinis strain CBS 6031, Rhodosporidium toruloides strain CBS 349 or Rhodosporidium toruloides strain CBS 14.

9. The process according to claim 1 wherein the polypeptide having epoxide hydrolase activity is derived from a host cell, comprising a recombinant DNA molecule which comprises a nucleotide sequence encoding at least a functional part of a polypeptide having epoxide hydrolase activity.

10. The process according to claim 9 , characterized in that a nucleotide sequence encoding at least a functional part of a polypeptide having epoxide hydrolase activity is derived from a microorganism belonging to the basidiomycetous yeast genera Rhodotorula and Rhodosporidium.

11. The process according to claim 9 , characterized in that a nucleotide sequence encoding at least a functional part of a polypeptide having epoxide hydrolase activity is derived from Rhodotorula glutinis, Rhodosporidium toruloides or Rhodosporidium toruloides.

12. The process according to claim 9 , characterized in that a nucleotide sequence encoding at least a functional part of a polypeptide having epoxide hydrolase activity is derived from Rhodotorula glutinis strain CBS 8761, Rhodotorula glutinis strain CBS 6031, Rhodosporidium toruloides strain CBS 349 or Rhodosporidium toruloides strain CBS 14.

13. The process according to claim 9 wherein the host cell is a bacterium.

14. The process according to claim 9 wherein the host cell is E. coli.

15. The process according to claim 9 wherein the host cell additionally comprises a recombinant DNA molecule which comprises a nucleotide sequence encoding for at least one recombinant chaperone or chaperonine.

16. The process according to claim 1 wherein the temperature is in the range of 0 to 50° C.

17. The process according to claim 1 wherein the pH value is in the range of 4 to 10.

18. The process according to claim 2 wherein the starting concentration of the epoxide according to general formula (I) is at least 80% of the solubility of said epoxide in the reaction media.

19. The process according to claim 1 further comprising providing a water miscible organic solvent or a water miscible organic solvent mixture in an effective amount at maximum, to prevent significant degeneration of polypeptide having epoxide hydrolase.

20. The process according to claim 1 wherein the resulting crude reaction mixture is worked up by selective extraction with two different solvents or two different solvent mixtures.

21. A process for preparing 2,3-dihydroxycarboxylic acids and derivatives thereof comprising hydrolyzing 2,3-epoxycarboxylic acids or derivatives thereof in the presence of a microorganism belonging to the basidiomycetous yeast genera Rhodotorula, Rhodosporidium and Trichosporon.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2006
From: BAYER AG
To: LANXESS DEUTSCHLAND GMBH
Reel/Frame 018463/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2003
From: WANDREY, CHRISTIAN; FILHO, MURILLO DE OLIVEIRA VILLELA; LIESE, ANDREAS; DE BONT, JAN A.M.; VERDOES, JAN C.; WEIJERS, CAREL A.G.M.; VISSER, J. HANS; DREISBACH, CLAUS
To: BAYER AKTIENGELLSCHAFT; FORSCHUNGSZENTRUM JUELICH GMBH
Reel/Frame 015362/0803 →